Prospective, open, multicentre study on the effect of fluticasone and formoterol in combination administered through Dry Powder Inhaler (DPI) compared to budesonide and formoterol in combination (Symbicort Turbuhaler) in the maintenance treatment of asthma in adults.

Trial Profile

Prospective, open, multicentre study on the effect of fluticasone and formoterol in combination administered through Dry Powder Inhaler (DPI) compared to budesonide and formoterol in combination (Symbicort Turbuhaler) in the maintenance treatment of asthma in adults.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 May 2014

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary) ; Budesonide/formoterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Libbs Farmaceutica
  • Most Recent Events

    • 09 Jul 2013 Primary endpoint 'Morning-peak-expiratory-flow-rate' has been met.
    • 09 Jul 2013 Results published in Respiratory Medicine.
    • 02 Jun 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top